Clinipace

Clinipace
Name	Clinipace
Type	Private
Industry	Clinical research
Founded	1997
Founder	Earl Bakken
Headquarters	Wilmington, Delaware
Key people	John Smith
Services	Clinical development, data management, regulatory affairs

Clinipace is a contract research organization that provides clinical development services to pharmaceutical, biotechnology, and medical device companies. Founded in the late 20th century, the company offers trial management, data management, and regulatory support across multiple therapeutic areas. Clinipace serves sponsors conducting Phase I–IV studies, working with academic medical centers, contract manufacturing organizations, and regulatory agencies.

History

Clinipace was established amid industry trends shaped by Food and Drug Administration regulatory reforms, Helsinki Declaration ethical frameworks, and globalization of clinical trials driven by World Health Organization guidance. Early growth paralleled consolidation waves exemplified by mergers like Pharmacia–Upjohn and acquisitions in the CRO sector such as Quintiles acquisitions. The company expanded services as technologies from Oracle Corporation clinical data platforms and standards from International Council for Harmonisation accelerated electronic data capture adoption. Over time Clinipace navigated market events including patent cliffs exemplified by Pfizer and strategic alliances like those between GlaxoSmithKline and academic consortia. Industry pressures from litigation such as high-profile cases involving Thalidomide and regulatory scrutiny after events like the Vioxx controversy influenced procedural reforms adopted by the firm. The organization’s trajectory intersected with larger healthcare shifts involving National Institutes of Health, European Medicines Agency, and multinational sponsor programs from Novartis and Roche.

Services and Specializations

Clinipace offers clinical trial management, biostatistics, pharmacovigilance, and regulatory affairs, interacting with tools and standards from MedDRA, CDISC, and ICH E6(R2). Trial operation services include site monitoring consistent with guidance from Good Clinical Practice authorities and data management using platforms competing with offerings from Medidata Solutions and Veeva Systems. Therapeutic area expertise spans oncology programs comparable to trials conducted by MD Anderson Cancer Center and cardiology protocols similar to work at Cleveland Clinic. The company supports vaccine development projects akin to efforts by Centers for Disease Control and Prevention, and device trials parallel to studies overseen by American College of Cardiology. Additional capabilities include real-world evidence studies using registries like FDA Sentinel and health economics modeling similar to analyses by Institute for Clinical and Economic Review.

Organizational Structure and Leadership

Clinipace’s leadership includes executive roles such as Chief Executive Officer, Chief Medical Officer, and Chief Financial Officer, mirroring governance models at Johnson & Johnson and Merck & Co.. Operational divisions include clinical operations, data sciences, regulatory, and pharmacovigilance comparable to organizational charts at Eli Lilly and Company and AstraZeneca. Board oversight engages independent directors with backgrounds from institutions like Harvard Medical School, Stanford University School of Medicine, and corporate governance practices observed at Bristol-Myers Squibb. Management liaises with institutional review boards such as Advarra and ethics committees aligned with protocols from World Medical Association.

Global Operations and Locations

Clinipace operates across regions including North America, Europe, and Asia, maintaining regional offices similar to the footprint of Parexel International and ICON plc. Major operational centers align with life sciences hubs such as Boston, Massachusetts, San Francisco Bay Area, London, Basel, and Singapore. The company runs multinational studies involving investigational sites at academic centers like Johns Hopkins Hospital, Mayo Clinic, and Imperial College London Hospital. Global pharmacovigilance connects with national regulators such as Health Canada and Therapeutic Goods Administration while supply chain coordination engages contract manufacturing organizations in regions including Shanghai and Mumbai.

Strategic Partnerships and Collaborations

Clinipace forms alliances with biotechnology firms, academic research organizations, and technology vendors. Collaborations parallel those between Genentech and academic consortia, or between Amgen and digital health startups. Technology partnerships include integrations with electronic data capture and clinical trial management systems from companies like Oracle Corporation and Veeva Systems. Research collaborations involve investigator-initiated studies at institutions such as UCSF Medical Center and multi-center networks similar to TransCelerate Biopharma initiatives. The firm also engages with contract manufacturing organizations such as Catalent and logistics providers resembling relationships with UPS Healthcare and DHL Global Forwarding for investigational product distribution.

Quality, Compliance, and Certifications

Quality systems at Clinipace adhere to standards from ISO 9001 and regulatory expectations from Food and Drug Administration and European Medicines Agency. Compliance programs reflect guidance from ICH and are benchmarked against industry best practices from Clinical Trials Transformation Initiative. Pharmacovigilance processes follow coding and reporting frameworks like MedDRA and safety reporting requirements overseen by agencies such as Pharmaceuticals and Medical Devices Agency. External audits often mirror inspection practices used by authorities in high-profile cases involving sponsors like GlaxoSmithKline and AstraZeneca.

Category:Contract research organizations